Waykole; Liladhar Murlidhar

Patent Applications and Registrations

Patent applications and USPTO patent grants for Waykole; Liladhar Murlidhar.The latest application filed is for "new crystalline forms of n-(3-(2-(2-hydroxyethoxy)-6-morpholinopyridin-4-yl)-4-methvlphenyl)-2 (trifluoromethyl)isonicotinamide as raf inhibitors for the treatment of cancer".

Company Profile

11.19.29

Waykole; Liladhar Murlidhar - Succasunna NJ
Waykole; Liladhar Murlidhar - Shanghai CN
Waykole; Liladhar Murlidhar - East Hanover NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
New Crystalline Forms Of N-(3-(2-(2-hydroxyethoxy)-6-morpholinopyridin-4-yl)-4-methvlphenyl)-2 (trifluoromethyl)isonicotinamide As Raf Inhibitors For The Treatment Of Cancer App 20220267299 - HARLACHER; Cornelius Stephen ; et al.	2022-08-25
Pharmaceutical Compositions Of Lipoic Acid Choline Ester Salts And Methods Of Treatment Using Same App 20210393671 - Bucher; Christoph ; et al.	2021-12-23
Crystalline Forms Of A Triazolopyrimidine Compound App 20210340152 - Huang; Ying ; et al.	2021-11-04
Pharmaceutical compositions of lipoic acid choline ester salts and methods of treatment using same Grant 11,135,239 - Bucher , et al. October 5, 2	2021-10-05
Pharmaceutical Compositions Of Lipoic Acid Choline Ester Salts And Methods Of Treatment Using Same App 20210283171 - Bucher; Christoph ; et al.	2021-09-16
Compositions And Methods For Modulating Farnesoid X Receptors App 20210253534 - CHIANELLI; Donatella ; et al.	2021-08-19
Crystalline forms of a triazolopyrimidine compound Grant 11,091,489 - Huang , et al. August 17, 2	2021-08-17
Compositions and methods for modulating farnesoid X receptors Grant 11,021,446 - Chianelli , et al. June 1, 2	2021-06-01
Aminopyridine Derivatives And Their Use As Selective Alk-2 Inhibitors App 20210155606 - ARISTA; Luca ; et al.	2021-05-27
Aminopyridine derivatives and their use as selective ALK-2 inhibitors Grant 10,947,218 - Arista , et al. March 16, 2	2021-03-16
Crystalline forms of 4-(2-((1R,2R)-2-hydroxycyclohexylamino)benzothiazol-6-yloxy)-N-methylpico- linamide Grant 10,934,273 - Grandeury , et al. March 2, 2	2021-03-02
Aminopyridine Derivatives And Their Use As Selective Alk-2 Inhibitors App 20200299265 - ARISTA; Luca ; et al.	2020-09-24
Compositions And Methods For Modulating Farnesoid X Receptors App 20200247757 - Kind Code	2020-08-06
Aminopyridine derivatives and their use as selective ALK-2 inhibitors Grant 10,710,980 - Arista , et al.	2020-07-14
Crystalline Forms Of 4-(2-((1r,2r)-2-hydroxycyclohexylamino)benzothiazol-6-yloxy)-n-methylpico- Linamide App 20200190057 - GRANDEURY; Arnaud ; et al.	2020-06-18
Salts of aza-bicyclic di-aryl ethers and methods to make them or their precursors Grant 10,421,755 - Marterer , et al. Sept	2019-09-24
Crystalline Forms Of A Triazolopyrimidine Compound App 20190211022 - HUANG; Ying ; et al.	2019-07-11
Aminopyridine Derivatives And Their Use As Selective Alk-2 Inhibitors App 20190161474 - ARISTA; Luca ; et al.	2019-05-30
Compositions And Methods For Modulating Farnesoid X Receptors App 20190062283 - CHIANELLI; Donatella ; et al.	2019-02-28
Salts Of Aza-bicyclic Di-aryl Ethers And Methods To Make Them Or Their Precursors App 20180009801 - Marterer; Wolfgang ; et al.	2018-01-11
Salts of aza-bicyclic di-aryl ethers and methods to make them or their precursors Grant 9,802,931 - Marterer , et al. October 31, 2	2017-10-31
Crystalline Forms Of 5-chloro-n2-(2-isopropoxy-5-methyl-4-piperidin-4-yl-phenyl)-n4-[2-(propan- E-2-sulfonyl)-phenyl]-pyrimidine-2, 4-diamine App 20160175305 - Feng; Lili ; et al.	2016-06-23
Salts of aza-bicyclic di-aryl ethers and pharmaceuticals thereof Grant 9,365,565 - Marterer , et al. June 14, 2	2016-06-14
Salts Of Aza-bicyclic Di-aryl Ethers And Methods To Make Them Or Their Precursors App 20160145253 - Marterer; Wolfgang ; et al.	2016-05-26
Crystalline forms of 5-chloro-N2-(2-isopropoxy-5-methyl-4-piperidin-4-yl-phenyl)-N4-[2-(propan- e-2-sulfonyl)-phenyl]-pyrimidine-2, 4-diamine Grant 9,309,229 - Feng , et al. April 12, 2	2016-04-12
Process for preparing 5-biphenyl-4-amino-2-methyl pentanoic acid Grant 9,206,116 - Hook , et al. December 8, 2	2015-12-08
Manufacturing process for pyrimidine derivatives Grant 9,181,215 - De La Cruz , et al. November 10, 2	2015-11-10
Process for Preparing 5-biphenyl-4-amino-2-methyl Pentanoic Acid App 20150166468 - Hook; David ; et al.	2015-06-18
Process for preparing 5-biphenyl-4-amino-2-methyl pentanoic acid Grant 8,993,785 - Hook , et al. March 31, 2	2015-03-31
Process for Preparing 5-biphenyl-4-amino-2-methyl Pentanoic Acid App 20140249320 - Hook; David ; et al.	2014-09-04
Salts Of Aza-bicyclic Di-aryl Ethers And Methods To Make Them Or Their Precursors App 20140220125 - Marterer; Wolfgang ; et al.	2014-08-07
Crystalline Forms Of 5-chloro-n2-(2-isopropoxy-5-methyl-4-piperidin-4-yl-phenyl)-n4-[2-(propan- E-2-sulfonyl)-phenyl]-pyrimidine-2, 4-diamine App 20130274279 - Feng; Lili ; et al.	2013-10-17
Manufacturing Process For Pyrimidine Derivatives App 20130225571 - Calienni; John Vincent ; et al.	2013-08-29
Salts of N-[6-cis-2,6-Dimethylmorpholin-4-yl)pyridine-3-yl]-2-methyl-4'-(t- rifluoromethoxy)[1,1'-biphenyl]-3-carboxamide App 20120214810 - Bajwa; Joginder Singh ; et al.	2012-08-23
Salts of N-[6-cis-2,6-Dimethylmorpholin-4-yl)pyridine-3-yl]-2-methyl-4'-(t- rifluoromethoxy)[1,1'-biphenyl]-3-carboxamide App 20120035174 - Bajwa; Joginder Singh ; et al.	2012-02-09
Salts of N-[6-cis-2,6-dimethylmorpholin-4-yl)pyridine-3-yl]-2-methyl-4'-(t- rifluoromethoxy)[1,1'-biphenyl]-3-carboxamide Grant 8,063,043 - Bajwa , et al. November 22, 2	2011-11-22
Salts of N-[6-cis-2,6-Dimethylmorpholin-4-yl)pyridine-3-yl]-2-methyl-4'-(t- rifluoromethoxy)[1,1'-biphenyl]-3-carboxamide App 20110178085 - Bajwa; Joginder Singh ; et al.	2011-07-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.